Neutrophils in Bronchoalveolar Lavage Fluid Indicating the Severity and Relapse of Pulmonary Sarcoidosis

被引:4
|
作者
Feng, Haoshen [1 ]
Yan, Lili [2 ]
Zhao, Yabin [3 ]
Li, Zhenhua [3 ]
Kang, Jian [3 ]
机构
[1] China Med Univ, Dept Pulm & Crit Care Med, Shengjing Hosp, Shenyang, Peoples R China
[2] Jinzhou Med Univ, Dept Pulm & Crit Care Med, Affiliated Hosp 1, Jinzhou, Peoples R China
[3] China Med Univ, Inst Resp Dis, Dept Pulm & Crit Care Med, Affiliated Hosp 1, Shenyang, Peoples R China
基金
国家重点研发计划;
关键词
pulmonary sarcoidosis; neutrophils; bronchoalveolar lavage fluid; severity; relapse; MATRIX METALLOPROTEINASES; SEVERE ASTHMA; CELLS; TARGETS;
D O I
10.3389/fmed.2021.787681
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundPulmonary sarcoidosis is a highly heterogeneous granulomatous disease without any specific symptoms and manifestations. Neutrophils in bronchoalveolar lavage fluid (BALF) have been proposed to indicate the severity and prognosis of pulmonary sarcoidosis, but this needs confirmation in patients from different populations due to the heterogeneity of the disease. This study aimed to determine the characteristics of patients with pulmonary sarcoidosis in northeastern China and to explore the relationship between neutrophils in BALF and the severity of pulmonary sarcoidosis. MethodsWe enrolled 432 patients who were diagnosed with pulmonary sarcoidosis in this retrospective study. The symptoms, extrapulmonary involvement, forced vital capacity percentage predicted (FVC % pred), and diffusing capacity of the lung for carbon monoxide percentage predicted (DLco % pred) were recorded. BAL was performed in 319 patients, and the results of a cellular examination of BALF were collected. A total of 123 patients who received corticosteroid treatment were followed up for at least 12 months, and the outcomes were recorded. ResultsCough was the most common symptom, and cutaneous involvement was the most common extrapulmonary manifestation in 304 (70.4%) and 82 (19.0%) patients, respectively. The percentages of patients with high neutrophil counts in BALF (>3%) were higher at Stages 2 and 3 compared with Stages 0 and 1 (33.2 vs. 19.4%, p = 0.007), although the percentages of neutrophils in BALF showed no difference between patients at Stages 0, 1, 2, and 3. Patients with high neutrophil counts in BALF had lower FVC % pred compared with the other patients (79.5 +/- 18.2 vs. 84.9 +/- 14.5%, p = 0.025) and were prone to relapse after corticosteroids were tapered. High neutrophil counts in BALF were independently associated with relapse after corticosteroids were tapered in a binary logistic regression analysis (p = 0.027). ConclusionsPatients with pulmonary sarcoidosis lacked specific symptoms and manifestations. The neutrophil count in BALF could indicate the severity and outcomes of pulmonary sarcoidosis.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] COMPARISON OF THE DIAGNOSTIC VALUE OF DIFFERENT LYMPHOCYTE SUBPOPULATIONS IN BRONCHOALVEOLAR LAVAGE FLUID IN PATIENTS WITH BIOPSY PROVEN SARCOIDOSIS
    Tanriverdi, Hakan
    Uygur, Firat
    Ornek, Tacettin
    Erboy, Fatma
    Altinsoy, Bulent
    Atalay, Figen
    Buyukuysal, Mustafa Cagatay
    Tekin, Ishak Ozel
    Arasli, Mehmet
    Tor, Muge Meltem
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2015, 32 (04) : 305 - 312
  • [42] Association between M1 and M2 macrophages in bronchoalveolar lavage fluid and tobacco smoking in patients with sarcoidosis
    Osinska, Iwona
    Wolosz, Dominika
    Domagala-Kulawik, Joanna
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2014, 124 (7-8): : 359 - 364
  • [43] Diagnostic Performance of Bronchoalveolar Lavage Fluid CD4/CD8 Ratio for Sarcoidosis: A Meta-analysis
    Shen, Yongchun
    Pang, Caishuang
    Wu, Yanqiu
    Li, Diandian
    Wan, Chun
    Liao, Zenglin
    Yang, Ting
    Chen, Lei
    Wen, Fuqiang
    EBIOMEDICINE, 2016, 8 : 302 - 308
  • [44] Chemokine receptor CXCR3 ligands in bronchoalveolar lavage fluid: associations with radiological pattern, clinical course, and prognosis in sarcoidosis
    Piotrowski, Wojciech J.
    Mlynarski, Wojciech
    Fendler, Wojciech
    Wyka, Krystyna
    Marczak, Jerzy
    Gorski, Pawel
    Antczak, Adam
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2014, 124 (7-8): : 395 - 402
  • [45] ELEVATION OF TUMOR-MARKERS IN SERUM AND BRONCHOALVEOLAR LAVAGE FLUID IN PULMONARY ALVEOLAR PROTEINOSIS
    HIRAKATA, Y
    KOBAYASHI, J
    SUGAMA, Y
    KITAMURA, S
    EUROPEAN RESPIRATORY JOURNAL, 1995, 8 (05) : 689 - 696
  • [46] Bronchoalveolar lavage fluid galactomannan detection for diagnosis of invasive pulmonary aspergillosis in chronic obstructive pulmonary disease
    Zhang, Xiao-Bin
    Chen, Gong-Ping
    Lin, Qi-Chang
    Lin, Xiao
    Zhang, Hong-Ying
    Wang, Ji-Hong
    MEDICAL MYCOLOGY, 2013, 51 (07) : 688 - 695
  • [47] Induced sputum versus bronchoalveolar lavage fluid in the evaluation of patients with idiopathic pulmonary fibrosis
    Antoniou, KM
    Alexandrakis, M
    Tzanakis, N
    Tsiligianni, I
    Tzortzaki, EG
    Siafakas, NM
    Bouros, DE
    RESPIRATION, 2005, 72 (01) : 32 - 38
  • [48] CXCL11 in bronchoalveolar lavage fluid and pulmonary function decline in systemic sclerosis
    Sfriso, P.
    Cozzi, F.
    Oliviero, F.
    Caso, F.
    Cardarelli, S.
    Facco, M.
    Fitta, C.
    Del Rosso, A.
    Matucci-Cerinic, M.
    Punzi, L.
    Agostini, C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (02) : S71 - S75
  • [49] Increased Bronchoalveolar Lavage Fluid CD1c Expressing Dendritic Cells in Idiopathic Pulmonary Fibrosis
    Tsoumakidou, M.
    Karagiannis, K. P.
    Bouloukaki, I.
    Zakynthinos, S.
    Tzanakis, N.
    Siafakas, N. M.
    RESPIRATION, 2009, 78 (04) : 446 - 452
  • [50] Proteomics and the lung: Analysis of bronchoalveolar lavage fluid
    Govender, Praveen
    Dunn, Michael J.
    Donnelly, Seamas C.
    PROTEOMICS CLINICAL APPLICATIONS, 2009, 3 (09) : 1044 - 1051